Author:
Siegmund Werner,Ludwig Karen,Engel Georg,Zschiesche Michael,Franke Gerd,Hoffmann Anna,Terhaag Bernd,Weitschies Werner
Reference35 articles.
1. Talinolol, ein klinisch bewährter β1‐selektiver Betablocker—Eine Übersicht zu pharmakokinetischen und pharmakodynamischen Eigenschaften;Schmidt;Perfusion,1995
2. Induction of P‐glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction;Westphal;Clin Pharmacol Ther,2000
3. Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans;Gramatté;Clin Pharmacol Ther,1996
4. Is the double peak phenomenon of talinolol caused by lymphatic transport?;Giessmann;Pharmacol Toxicol,2001
5. Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P‐glycoprotein;Westphal;Clin Pharmacol Ther,2000
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献